A one-year trial to assess the value of orlistat in the management of obesity

International Journal of Obesity

Volumn 21, Issue SUPPL. 3, 1997, Pages

  James, W P T ^a   Avenell, A ^b,c   Broom, J ^b   Whitehead, J ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Calorie restricted diet; Lipase inhibition; Obesity; Orlistat; Weight loss

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; ENZYME INHIBITOR; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; VITAMIN; VITAMIN D;

ADULT; ANTHROPOMETRY; BLOOD CHEMISTRY; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; BRADYCARDIA; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GALLBLADDER; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KIDNEY; LIPID BLOOD LEVEL; MALE; METHODOLOGY; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; VITAMIN BLOOD LEVEL; VOMITING; WEIGHT REDUCTION;

ADULT; BODY WEIGHT; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENZYME INHIBITORS; FEMALE; HUMANS; LACTONES; LIPASE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 0030908378     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Foreyt J, Goodrick K. The ultimate triumph of obesity. Lancet 1995; 346: 134-135.
2. Pi-Sunyer, FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-660.
3. Health of the Nation. Department of Health: London, 1992.
4. SIGN. Obesity in Scotland: Integrating Prevention with Weight Management. A National Clinical Guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Pilot Edition. November 1996.
5. Blundell JE, Halford JCG. Pharmacological aspects of obesity treatment: towards the 21st century. Int J Obes 1995; 19 (Suppl 3): S51-S55.
6. Hauptman JB, Jeunet FS, Hartmann D. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro18-0647 (tetrahydrolipstatin). Am J Clin Nutr 1992; 55: 309S-313S.
7. Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH. Retrospective population-based analysis of the dose-response (faecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994; 56: 82-85.
8. Lean ME, James WP. Prescription of diabetic diets in the 1980s. Lancet 1986; 1: 723-725.
9. Schofield WN, Schofield C, James WPT. Basal metabolic rate - review and prediction, together with an annotated bibliography of source material. Hum Nutr Clin Nutr 1985; 39C (Suppl 1): 1-96.
10. World Health Organization. Energy and Protein Requirement. Report of a joint FAO/WHO/UNU Expert Consultation. Technical Report Series 724, World Health Organization, Geneva, 1985.
11. James WPT, Schofield EC. Human Energy Requirements: A Manual for Planners and Nutritionists. Published by arrangement with the Food and Agriculture Organization of the United Nations. Oxford University Press, 1990.
12. World Health Organization. Diet nutrition and the prevention of chronic diseases. Report of a WHO study group. Technical Report Series 787. World Health Organization, Geneva, 1990.
13. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; I: 1142-1145.
14. Garrow JS. Should obesity be treated? Treatment is necessary. BMJ 1994; 309: 654-655.
15. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Modest intentional weight loss increases life expectancy in overweight women. Am J Epidemiol 1995; 141: 1128-1141.
16. Thomas PR (ed). Weighing the Options. Criteria for Evaluating Weight Management Programs. National Academic Press: Institute of Medicine, Washington, 1995.
17. Frost G, Masters K, Kings C, Kelly M, Hasan U, Heavens P, White R, Stanford J. A new method of energy prescription to improve weight loss. J Hum Nutr Dietetics 1991; 4: 369-373.
18. Sullivan M, Karlsson J, Sjöström L. Swedish Obese Subjects (SOS) - An interventional study of obesity. Two-year follow-up of health and psychosocial functioning. Int J Obes 1994; 18 (Suppl 2): abstr.
19. Jecquier E. The Problem of Obesity and Its Management. In: Diet, Nutrition and Chronic Disease - Lessons from Contrasting Worlds. eds Shetty PS, McPherson, K. John Wiley & Sons, 1997. Chichester, UK.
20. Leibel RL, Hirsch J, Appel BE, Checani G. Energy intake required to maintain body weight is not affected by wide variation in diet composition. Am J Clin Nutr 1992; 55: 350-355.
21. Heitmann BL, Lissner L, Sorensen TIA, Bengtsson C. Does dietary fat intake promote subsequent weight gain in genetically predisposed individuals? Int J Obes 1993; 17: 108 (abstr).